(0.40%) 5 038.33 points
(0.42%) 38 062 points
(0.82%) 15 733 points
(0.00%) $79.00
(5.02%) $2.03
(0.09%) $2 313.00
(0.30%) $26.83
(0.85%) $963.00
(-0.02%) $0.933
(-0.19%) $11.01
(0.03%) $0.799
(-1.44%) $91.92
4 days till quarter result
(bmo 2024-05-06)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure...
Stats | |
---|---|
Šios dienos apimtis | 484 705 |
Vidutinė apimtis | 448 892 |
Rinkos kapitalizacija | 11.80B |
EPS | €0 ( 2024-02-19 ) |
Kita pelno data | ( €0.550 ) 2024-05-06 |
Last Dividend | €1.120 ( 2023-05-17 ) |
Next Dividend | €0 ( N/A ) |
P/E | 23.65 |
ATR14 | €0.0260 (0.06%) |
Tūris Koreliacija
Fresenius Medical Care AG Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Fresenius Medical Care AG Koreliacija - Valiuta/Žaliavos
Fresenius Medical Care AG Finansinės ataskaitos
Annual | 2023 |
Pajamos: | €19.45B |
Bruto pelnas: | €4.93B (25.32 %) |
EPS: | €1.700 |
FY | 2023 |
Pajamos: | €19.45B |
Bruto pelnas: | €4.93B (25.32 %) |
EPS: | €1.700 |
FY | 2022 |
Pajamos: | €19.40B |
Bruto pelnas: | €5.31B (27.37 %) |
EPS: | €2.30 |
FY | 2021 |
Pajamos: | €17.62B |
Bruto pelnas: | €5.08B (28.82 %) |
EPS: | €3.30 |
Financial Reports:
No articles found.
Fresenius Medical Care AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.120 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.230 | 2000-05-31 |
Last Dividend | €1.120 | 2023-05-17 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 26 | -- |
Total Paid Out | €18.29 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.96 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.60 | |
Div. Directional Score | 7.32 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NOEJ.DE | Ex Dividend Junior | 2023-05-12 | Annually | 0 | 0.00% | |
ABR.DE | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
GDX.DE | Ex Dividend Knight | 2023-10-05 | Quarterly | 0 | 0.00% | |
PSQ.F | Ex Dividend Knight | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
BC8.DE | Ex Dividend Knight | 2023-05-26 | Annually | 0 | 0.00% | |
IBE1.DE | Ex Dividend Knight | 2023-07-07 | Semi-Annually | 0 | 0.00% | |
ST5.DE | No Dividend Player | 2023-06-26 | Annually | 0 | 0.00% | |
COP.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
LHOG.F | Ex Dividend Junior | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
V6C.DE | Ex Dividend Junior | 2023-06-01 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0281 | 1.500 | 9.44 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0161 | 1.200 | 9.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0398 | 1.500 | -0.669 | -1.004 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.424 | 0.800 | 7.88 | 6.30 | [1 - 3] |
quickRatioTTM | 0.916 | 0.800 | 9.32 | 7.45 | [0.8 - 2.5] |
cashRatioTTM | 0.230 | 1.500 | 9.84 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.355 | -1.500 | 4.08 | -6.12 | [0 - 0.6] |
interestCoverageTTM | 3.47 | 1.000 | 9.83 | 9.83 | [3 - 30] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 6.69 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.885 | -1.500 | 6.46 | -9.69 | [0 - 2.5] |
grossProfitMarginTTM | 0.253 | 1.000 | 9.11 | 9.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0710 | 1.000 | -0.580 | -0.580 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.218 | 1.000 | 9.90 | 9.90 | [0.2 - 2] |
assetTurnoverTTM | 0.573 | 0.800 | 9.51 | 7.61 | [0.5 - 2] |
Total Score | 11.04 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 21.26 | 1.000 | 7.95 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0398 | 2.50 | -0.430 | -1.004 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.63 | 2.00 | 7.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.83 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 8.96 | 2.00 | 7.01 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -5.05 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.135 | 1.000 | 9.12 | 0 | [0.1 - 0.5] |
Total Score | 3.60 |
Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.